Arca
Skip to content

HemosIL Liquid Anti-Xa

Anti-Factor Xa Activity Test System, Apixaban. De Novo DEN190032, from Instrumentation Laboratory CO (Bedford, MA). Product code QLU, class 2.

As of Nov 17, 2026, DEN190032 is an FDA De Novo held by Instrumentation Laboratory CO, granted on Sep 17, 2020 after 450 days, with no recalls tied to it in FDA's recall database.

  • Granted: Sep 17, 2020
  • Review time: 450 days
  • Recalls: 0
  • Cited as a predicate by: 3 devices

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

HemosIL Liquid Anti-Xa is an automated chromogenic assay for in vitro diagnostic use by laboratory professionals in clinical laboratories. The assay provides quantitative results on 3.2% citrated human plasma for the following analytes based on the calibrators used: • When used with HemosIL Heparin Calibrators: Quantitative determination of unfractionated heparin (UFH) and low molecular weight…

Pivotal Study

The main clinical evidence FDA relied on, as its decision summary describes it
Design
Method comparison study of clinical samples from apixaban patients vs. LC-MS/MS reference method
Enrolled
367
Where
3 sites, US
Primary endpoint
Agreement with validated apixaban LC-MS/MS method (linear regression of slope, intercept, correlation)
Result
n=367; r=0.995; slope 1.101; intercept -2.458; acceptance criteria not stated

Cited as a Predicate

3 later 510(k) summaries name this device as a predicate

Other QLU Clearances

The newest 510(k)s for the same product code; see every QLU device

Record

Type
Direct
Received
Jun 25, 2019
Review panel
Hematology
Regulation
21 CFR 864.7295

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.